Pre-emptive treatment of recurrent hepatitis C infection

被引：7

作者：

Charlton, M ^{[1
]}

机构：

[1] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA

来源：

LIVER TRANSPLANTATION | 2002年 / 8卷 / 10期

关键词：

D O I：

10.1053/jlts.2002.35859

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Data discussed in summary suggest that post-LT HCV infection may be most amenable to therapy initiated on a prophylactic basis early in the post-LT course. However, a definitive comparison of the safety and efficacy of antiviral therapy initiated prophylactically versus on histological recurrence has not been performed, nor has any large study of antiviral therapy of post-LT HCV infection.

引用

页码：S50 / S54

页数：5

共 53 条

[1] Epidemiology of hepatitis C [J].

Alter, MJ .

HEPATOLOGY, 1997, 26 (03) :S62-S65

[2]

ASCHER NL, 1994, HEPATOLOGY, V20, pS24

[3]

Bellati G., 1999, Journal of Hepatology, V30, P51

[4]

BELLE SH, 1997, CLIN TRANSPLANTS 199, P15

[5] Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation [J].

Bizollon, T ;

Palazzo, U ;

Ducerf, C ;

Chevallier, M ;

Elliott, M ;

Baulieux, J ;

Pouyet, M ;

Trepo, C .

HEPATOLOGY, 1997, 26 (02) :500-504

[6] Long-term outcome of hepatitis C virus infection after liver transplantation [J].

Boker, KHW ;

Dalley, G ;

Bahr, MJ ;

Maschek, H ;

Tillmann, HL ;

Trautwein, C ;

Oldhaver, K ;

Bode, U ;

Pichlmayr, R ;

Manns, MP .

HEPATOLOGY, 1997, 25 (01) :203-210

[7] Long-term outcome of hepatitis C infection after liver transplantation [J].

Cane, EJ ;

Portmann, BC ;

Naoumov, NV ;

Smith, HM ;

Underhill, JA ;

Donaldson, PT ;

Maertens, G ;

Williams, R .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (13) :815-820

[8] Predictors of patient and graft survival following liver transplantation for hepatitis C [J].

Charlton, M ;

Seaberg, E ;

Wiesner, R ;

Everhart, J ;

Zetterman, R ;

Lake, J ;

Detre, K ;

Hoofnagle, J .

HEPATOLOGY, 1998, 28 (03) :823-830

[9]

Crippin JS, 2000, HEPATOLOGY, V32, p308A

[10] Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C [J].

Davis, GL ;

Esteban-Mur, R ;

Rustgi, V ;

Hoefs, J ;

Gordon, SC ;

Trepo, C ;

Shiffman, ML ;

Zeuzem, S ;

Craxi, A ;

Ling, MH ;

Albrecht, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21) :1493-1499

← 1 2 3 4 5 6 →